GSK and Sanofi join FinnGen, a large scale genome study of the Finnish population

(University of Helsinki) GSK and Sanofi have joined the FinnGen study, a large public private partnership aiming to collect and analyse genome and health data from 500 000 Finns and thereby generate novel medically and therapeutically relevant insights.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news